Outcomes of short‐duration antiviral prophylaxis for hepatitis C positive donor kidney transplants
出版年份 2021 全文链接
标题
Outcomes of short‐duration antiviral prophylaxis for hepatitis C positive donor kidney transplants
作者
关键词
-
出版物
AMERICAN JOURNAL OF TRANSPLANTATION
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-07-02
DOI
10.1111/ajt.16747
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study
- (2020) Jordan J Feld et al. Lancet Gastroenterology & Hepatology
- High prevalence of injection drug use and blood-borne viral infections among patients in an urban emergency department
- (2020) Erik S. Anderson et al. PLoS One
- Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C–Viremic Donors to Hepatitis C–Negative Recipients: An Open-Label Nonrandomized Study
- (2020) Christine M. Durand et al. ANNALS OF INTERNAL MEDICINE
- Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection
- (2020) Meghan E. Sise et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study
- (2019) Antonio Franco et al. TRANSPLANT INTERNATIONAL
- Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update
- (2019) Elise J. Smolders et al. CLINICAL PHARMACOKINETICS
- Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients
- (2019) Ann E. Woolley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience
- (2019) Miklos Z. Molnar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Fibrosing cholestatic hepatitis after kidney transplantation from HCV ‐viremic donors to HCV ‐negative recipients: A unique complication in the DAA era
- (2019) Nikhil Kapila et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Ultra‐short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients
- (2019) Gaurav Gupta et al. AMERICAN JOURNAL OF TRANSPLANTATION
- HCV NAT positive solid organ allografts transplanted into HCV negative recipients: A real‐world experience
- (2019) Nikhil Kapila et al. HEPATOLOGY
- Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients
- (2018) Christine M. Durand et al. ANNALS OF INTERNAL MEDICINE
- The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States
- (2018) Christine M. Durand et al. ANNALS OF INTERNAL MEDICINE
- The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection
- (2018) Kimberly L. Garrison et al. DRUG METABOLISM AND DISPOSITION
- Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation
- (2018) Guillermo A. Ortiz et al. Hemodialysis International
- The removal of DAA restrictions in Europe – one step closer to eliminating HCV as a major public health threat
- (2018) Alison D. Marshall et al. JOURNAL OF HEPATOLOGY
- Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient
- (2018) Donald F. Chute et al. KIDNEY INTERNATIONAL
- Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study
- (2018) Charitha Gowda et al. Open Forum Infectious Diseases
- Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients
- (2018) Peter P. Reese et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection
- (2018) Steven Flamm et al. Clinical Gastroenterology and Hepatology
- Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients
- (2017) David S. Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C
- (2016) Polina German et al. CLINICAL PHARMACOKINETICS
- External Validation of the Estimated Posttransplant Survival Score for Allocation of Deceased Donor Kidneys in the United States
- (2014) P. A. Clayton et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
- (2012) Bruno Sainz et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started